For any further information
Who we are
Resono Ophthalmic is an Italian company that produces highly innovative therapeutic devices for the eye-care domain. The key feature of these devices is the exploitation of Quantum Molecular Resonance (QMR®), a patented technique capable of stimulating the natural cellular and tissue regeneration via low-power high-frequency electric fields.
Our Mission
Our mission is to contribute to improving the quality of patient’s life by providing ground-breaking solutions that effectively treat a range of eye syndromes and diseases.Reinvent Dry Eye Treatment
Rexon-Eye is a non-invasive device that provides durable treatment for all forms of dry eye syndromes. It works by applying low-power high-frequency electric fields, capable of stimulating the metabolism and natural regeneration of cells.
The treatment addresses all types of the dry eye syndromes, both evaporative and hypo-secretive, as evidenced by several subjective and objective measurements.
Newsroom
RESONO OPHTHALMIC at ESCRS 2021, Amsterdam
RESONO OPHTHALMIC will attend the 39th Congress of the ESCRS in Amsterdam, from 8th to 10th...
Resono at ACOS conference to present QMR technology | Paris, 18th September
With a speech on QMR® technology for Ophthalmology, Resono will be participating in the round...
Latest Rexon-Eye clinical trial presentation
RESONO OPHTHALMIC has just participated to the ARVO 2021 Annual Meeting with a presentation about...